Clarification of risk factors for hepatectomy in patients with hepatocellular carcinoma

Hepato-Gastroenterology

Volumn 49, Issue 48, 2002, Pages 1625-1631

  Ishikawa, M ^a   Yogita, S ^a   Miyake, H ^a   Fukuda, Y ^a   Harada, M ^a   Wada, D ^a   Tashiro, S ^a  

^a National Hospital Organization Kochi National Hospital   (Japan)

Author keywords

Hepatectomy; Hepatocellular carcinoma; HGF

Indexed keywords

CYTOKINE; ENDOTOXIN; GRANULOCYTE COLONY STIMULATING FACTOR; INDOCYANINE GREEN; INTERLEUKIN 6; INTERLEUKIN 8; SCATTER FACTOR;

ABDOMINAL SURGERY; ADULT; AGED; ARTICLE; CANCER MORTALITY; CANCER PATIENT; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; FEMALE; HUMAN; INCIDENCE; INTRAOPERATIVE PERIOD; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; LIVER RESECTION; MAJOR CLINICAL STUDY; MALE; MULTIPLE REGRESSION; POSTOPERATIVE COMPLICATION; POSTOPERATIVE INFECTION; POSTOPERATIVE PERIOD; PREDICTION; PREOPERATIVE PERIOD; PRIORITY JOURNAL; RISK FACTOR; STATISTICAL MODEL;

ADULT; AGED; CARCINOMA, HEPATOCELLULAR; CHI-SQUARE DISTRIBUTION; COLORING AGENTS; CYTOKINES; FEMALE; HEPATECTOMY; HEPATOCYTE GROWTH FACTOR; HUMANS; INCIDENCE; INDOCYANINE GREEN; LIVER CIRRHOSIS; LIVER FUNCTION TESTS; LIVER NEOPLASMS; LOGISTIC MODELS; MALE; MIDDLE AGED; POSTOPERATIVE COMPLICATIONS; PREDICTIVE VALUE OF TESTS; RISK FACTORS; TREATMENT OUTCOME;

EID: 0036841652     PISSN: 01726390     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (33)

1. Wiezer MJ, Meijer C, Vulysteke R, Pullens RH, Prins HA, Cuesta MA, Meijer S, Hack CE, van Leeuwen PAM: Is major liver surgery associated with an increased systemic inflammatory response? A prospective comparison of hemihepatectomy and other major abdominal surgery. Liver 1999; 19:220-227.
2. Miyagawa S, Makuuchi M, Kawasaki S, Kakazu T: Criteria for safe hepatic resection. Am Surg 1995; 169:589-594.
3. Yamanaka N, Okamoto E, Kuwata K, Tanaka N: Amultiple regression equation for prediction fo posthepatectomy liver failure. Ann Surg 1984; 200:658-663.
4. Stimpson RE, Pellegrini CA, Way KW: Factors affecting the morbidity of elective liver resection. Am J Surg 1987; 153:189-195.
5. Pugh RNH, Murray-Lyon IM, Dawson JL, Pietroni ML, Williams R: Transection of the oesophagus for bleeding varices. Br J Surg 1973; 60:646-649.
6. Tsao JI, Loftus JP, Nagorney DM, Adson MA, Ilstrup DM: Trends in morbidity and mortality of hepatic resection for malignancy A matched comparative analysis. Ann Surg 1994; 220:199-205.
7. Lau H, Man K, Fan ST, Yu WC, Lo CM, Wong J: Evaluation of preoperative hepatic function in patients with hepatocellular carcinoma undergoing hepatectomy. Br J Surg 1997; 84:1255-1589.
8. Fan ST, Lo CM, Liu CL, Lam CM, Yuen WK, Yeung C, Wong J: Hepatectomy for hepatocellular carcinoma: Toward Zero hospital deaths. Ann Surg 1999; 229:322-330.
9. Bolder U, Brune A, Schmidt S, Tacke J, Jauch KW, Lohlein D: Preoperative assessment of mortality risk in hepatic resection by clinical variables: A multivariate analysis. Liver Transplant Surg 1999; 5:227-237.
10. Belghiti J, Hiromatsu K, Benoist S, Massult PP, Sauvanet A, Farges O: Seven hundred forty-hepatectomies in the 1990s: An update to evaluate the actual risk of liver resection. J Am Coll Surg 2000; 191:38-46.
11. Enayati P, Brennan MF, Fong Y: Systemic and liver cytokine activation Implications for liver regeneration and posthepatectomy endotoxemia and sepsis. Arch Surg 1994; 129:1159-1164.
12. Kristiansson M, Soop M, Saraste L, Sundqvist KG: Post-operative circulating cytokine patters- the influence of infection. Intensive Care Med 1993; 19:395-400.
13. Miki C, Iriyama K, Strain A, Harrison JD, Hirono S, Gunson BK, Sherwell JM, Suzuki H, McMaster P: Clinical significance of serum hepatocyte growth factor in orthotopic liver transplantation. Surgery 1996; 119:505-510.
14. Kimura F, Miyazaki M, Suwa T, Kadoyama C, Itoh H, Ambiru S, Shimizu H, Nakagawa K: Correlation between human hepatocyte growth factor and interleukin-6 concenration after surgery. Hepatogastroenterology 1999; 46:1030-1035.
15. Hu RH, Lee PH, Yu SC, Sheu JC, Lai MY: Serum hepatocyte growth factor before and after resection for hepatocellular carcinoma. Hepatogastroenterology 1999; 46:1842-1847.
16. Nordinger B, Parc R, Delva E, Quilichini MA, Hannoun L, Huguet C: Hepatic resection for colorectal liver metastases. Ann Surg 1987; 205:256-263.
17. Kanematsu T, Takenaka K, Matsumata T, Furuta T, Sugimachi K, Inokuchi K: Limited hepatic resection effective for selected cirrhotic patients with primary liver cancer. Ann Surg 1984; 199:51-56.
18. Cohnert TU, Rau HG, Buttler E, Hernandez-Richter T, Sauter G, Reuter C, Schilberg FW: Preoperative risk assessment of resection for malignant disease. World J Surg 1997; 21:396-401.
19. Sitzmann JV, Greene PS: Perioperative predictors of morbidity following hepatic resection for neoplasm. Ann Surg 1994; 219:13-17.
20. Belghiti J, Noun R, Zane E, Ballet T, Sauvanet A: Portal triad clamping or hepatic vascular exclusion for major liver resection. A controlled study. Ann Surg 1996; 224:155-161.
21. Bismuth H, Castaing D, Garden J: Major hepatic resection under total vascular exclusion. Ann Surg 1989; 210:13-19.
22. Delva E, Camus Y, Nordlinger B, Hannoun L, Parc R, Deraz H, Huguet C: Vascular occlusion for liver resections operative management and tolerance to hepatic ischemia: 142 cases. Ann Surg 1989; 209:211-218.
23. Descottes B, Thognon P, Valleix D, Mendler MH: major liver resection without vascular clamping: Retrospective study and 84 cases. Hepatogastroenterology 1998; 45:364-367.
24. Nonami T, Nakao A, Kurokawa T, Inagaki H, Matsushita Y, Sakamoto J, Takagi H: Blood loss and ICG clearance as best prognostic markers of post-hepatectomy liver failure. Hepatogastroenterology 1999; 46:1669-1672.
25. Garrison RN, Cryer HM, Howard DA, Polk HC: Clarification of risk factors for abdominal operations in patients with hepatic cirrhosis. Ann Surg 1984; 199:648-655.
26. Kragsbjerg P, Holmberg H, Vikerfors T: Serum concentrations of interleukin-6, tumor necrosis factor-α and C-reactive protein in patients undergoing major operations. Eur J Surg 1995; 161:17-22.
27. Sautner T, Fugger R, Gotzinger P, Mittlbock M, Winkler S, Roth E, Steinnger R, Muhlbacher F: Tumor necrosis factor-α and interleukin-6: Early indications of bacterial infection after human orthotopic liver transplantation. Eur J Surg 1995; 161:97-101.
28. Ishikawa M, Miyauchi T, Yagi K, Chikaishi H, Fukuta Y, Miyake H, Harada M, Yogita S, Tashiro S: Clinical revelance of antibiotic-induced endotoxin release in patients undergoing hepatic resection. World J Surg 1999; 23:75-79.
29. Nolam JP: Endotoxin, reticuloendothelial function and liver injury. Hepatology 1981; 1:458-465.
30. Yanagita K, Nagaike M, Ishibashi H, Niho Y, Matsumoto K, Nakamura T: Lung may have an endocrine function producing hepatocyte growth factor in response to injury of distal organs. Biochem Biophys Res Commun 1992; 182:802-809.
31. Shiota G, Okano J, Kawasaki H, Kawamoto H, Nakamura T: Serum hepatocyte growth factor levels in liver disease: clinical implication. Hepatology 1995; 21:106-112.
32. Kimura F, Miyazaki M, Suwa T, Kakizawa S, Itoh H, Kaiho T, Ambiru S, Shimizu H, Tagawa A: Increased levels of human hepatocyte growth factor in serum and peritoneal fluid after partial hepatectomy. Am J Gastroenterol 1996; 91:116-121.
33. Miyazawa K, Tsubouchi H, Naka D, Takahashi K, Okigaki M, Arakaki N, Nakayama H, Hirono S, Sakiyama O, Takahashi K: Molecular clonings and sequence analysis of cDNA for human hepatocyte growth factor. Biochem Biophys Res Commun 1989; 163:967-973.f